surmount-1 week 12 weight loss tirzepatide reduction with different doses of in Surmount 1 SURMOUNT-1: Tirzepatide Drastically Reduces Weight

What the Numbers Reveal The competitive picture heading into the second half of 2026 is defined by three dynamics

Certain genetic variantssuch as FTO rs9939609 and MC4R rs17782313correlate with how efficiently your body manages weight and fluid balance

Serious Adverse Events Both medications carry the same class-wide warnings: risk of pancreatitis, gallbladder disease (particularly at higher rates of weight loss), and a theoretical risk of medullary thyroid carcinoma (MTC) based on rodent studies

Avoid high-fat and very sweet foods early on they are the most common reported triggers for nausea and vomiting in clinical observation